SEC Form 4 · accession 0001062993-16-007310
BIOSPECIFICS TECHNOLOGIES CORP · BSTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Schamroth
Director
Period of report
Jan 27, 2016
Accepted (ET)
Jan 27, 2016 · 12:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875622
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value | Jan 27, 2016 | M | 15,000 | $5.15 | A | 69,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.15 | Jan 27, 2016 | M | 15,000 | D | — | Sep 5, 2017 | Common Stock; $0.001 par value | 15,000 | 0 | D |
Explanation of responses
- F1The option was granted on 09/06/2007 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested.